Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial

Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial

Abstract Background Fibroadenoma (FA) is the most common benign solid breast mass in women, with no definite method of management. Because fibroadenoma is dependent on female sex hormones and comprises hypertrophic changes at cellular levels, we investigated the effects of metformin (MF), a safe hyp...

Full description

Bibliographic Details
Main Authors: Sadaf Alipour, Mahboubeh Abedi, Azin Saberi, Arezoo Maleki-Hajiagha, Firoozeh Faiz, Saeed Shahsavari, Bita Eslami
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Endocrine Disorders
Subjects:
Fibroadenoma
Fibrocystic Breast Disease
Breast Ultrasonography
Metformin
Therapy
Online Access:https://doi.org/10.1186/s12902-021-00824-4

Internet

https://doi.org/10.1186/s12902-021-00824-4

Similar Items